February 8, 2017 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Ultratech, Inc. (NASDAQ:UTEK), was announced concerning whether the takeover of Ultratech, Inc. by Veeco Instruments Inc for a value of approximately $28.64 per share is unfair to NASDAQ:UTEK stockholders.

The investigation by a law firm concerns whether certain officers and directors of Ultratech, Inc. breached their fiduciary duties owed to NASDAQ:UTEK investors in connection with the proposed acquisition.

On February 2, 2017, Veeco Instruments Inc. and Ultratech, Inc. (NASDAQ:UTEK) announced that they have signed an agreement for Veeco Instruments Inc. to acquire Ultratech, Inc. (NASDAQ:UTEK). Under the terms of the transaction Ultratech, Inc. (NASDAQ:UTEK) shareholders will receive $21.75 per share in cash and 0.2675 of a share of Veeco common stock for each Ultratech common share outstanding. Based on Veeco's closing stock price on February 1, 2017, the transaction consideration is valued at approximately $28.64 per Ultratech share.

However, given that at least one analyst has set the high target price for NASDAQ:UTEK shares at $30.00 per share, the investigation concerns whether the offer is unfair to NASDAQ:UTEK stockholders. More specifically, the investigation concerns whether the Ultratech Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

Ultratech, Inc. reported that its annual Total Revenue rose from $149.18 million in 2015 to $194.05 million in 2016 and that its Net Loss of $15.13 million in 2015 turned to a Net Income of $11.24 million in 2016.